Indeed, in subjects with Braak stage III–VI, we observed higher expression of CP13-ir, AT8-ir, and PHF1-ir in T2DM subjects, indicating exacerbated neuropathological changes associated with AD progression. This evidence concerns the gene PHF1 and Alzheimer disease.